Tryptamine Therapeutics to Issue New Shares on ASX
Company Announcements

Tryptamine Therapeutics to Issue New Shares on ASX

Tryptamine Therapeutics (AU:TYP) has released an update.

Tryptamine Therapeutics Limited has announced a non-pro rata offer to issue 10,000 ordinary fully paid shares, with the closing date for acceptances set for November 13, 2024. The proposed issue date for the securities is also November 13, 2024. This move is part of the company’s strategy to raise capital through the Australian Securities Exchange (ASX).

For further insights into AU:TYP stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App